BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.
暂无分享,去创建一个
A. Stenzinger | A. von Deimling | M. Preusser | D. Capper | F. Lasitschka | A. Kulozik | F. Sahm | G. Mechtersheimer | Jochen Meyer | I. Anagnostopoulos | A. Berghoff | Marion Schneider | L. Müllauer | A. Habel | Jochen Meyer
[1] W. Weichert,et al. Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia , 2012, The American journal of surgical pathology.
[2] M. Copin,et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. , 2012, Blood.
[3] C. von Kalle,et al. BRAF inhibition in refractory hairy-cell leukemia. , 2012, The New England journal of medicine.
[4] M. Brown,et al. Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial , 2012, The Lancet.
[5] F. Fraternali,et al. B-RAF Mutant Alleles Associated with Langerhans Cell Histiocytosis, a Granulomatous Pediatric Disease , 2012, PloS one.
[6] O. Abla,et al. Langerhans cell histiocytosis and Erdheim–Chester disease , 2012, Current opinion in rheumatology.
[7] B. Rollins,et al. Recent advances in the understanding of Langerhans cell histiocytosis , 2012, British journal of haematology.
[8] T. Eberlein,et al. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation , 2012 .
[9] H. Zentgraf,et al. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody , 2011, Acta Neuropathologica.
[10] Kirsten Schmieder,et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.
[11] K. Flaherty. Narrative Review: BRAF Opens the Door for Therapeutic Advances in Melanoma , 2010, Annals of Internal Medicine.
[12] R. Arceci,et al. BRAF, a piece of the LCH puzzle. , 2010, Blood.
[13] W. Hahn,et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. , 2010, Blood.
[14] Kathleen M Murphy,et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. , 2010, The Journal of molecular diagnostics : JMD.
[15] M. Merad,et al. Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells , 2010, The Journal of Immunology.
[16] Markus G. Manz,et al. Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.
[17] G. Makrigiorgos,et al. COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. , 2009, Clinical chemistry.
[18] R. Edelson,et al. The balance between immunity and tolerance: The role of Langerhans cells , 2009, Cellular and Molecular Life Sciences.
[19] S. Gibbs,et al. Transcriptional profiling of human skin‐resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions , 2008, Journal of leukocyte biology.
[20] Tu V. Huynh,et al. Clonal cytogenetic abnormalities in Erdheim-Chester disease. , 2007, The American journal of surgical pathology.
[21] J. Banchereau,et al. Increased Blood Myeloid Dendritic Cells and Dendritic Cell-Poietins in Langerhans Cell Histiocytosis1 , 2005, The Journal of Immunology.
[22] B. Petersen,et al. p53 Expression in Biopsies From Children With Langerhans Cell Histiocytosis , 2002, Journal of pediatric hematology/oncology.
[23] C. Bodemer,et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. , 2001, Blood.
[24] J. Davoust,et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. , 2000, Immunity.
[25] P. Soler,et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. , 1999, Journal of immunology.
[26] V. Paradis,et al. Chester-Erdheim disease: a neoplastic disorder. , 1999, Human pathology.
[27] J. Banchereau,et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface , 1999, European journal of immunology.
[28] Loise M. Francisco,et al. Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.
[29] K. Bhatia,et al. p53 Expression in Langerhans Cell Histiocytosis , 1998, Journal of pediatric hematology/oncology.
[30] A. Mackensen,et al. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis , 1997, British journal of haematology.
[31] L. Yesner,et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.
[32] P. Gaulard,et al. Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. , 1995, The American journal of surgical pathology.
[33] N. Brousse,et al. Langerhans' cell histiocytosis cells are activated langerhans' cells , 1994, The Journal of pathology.
[34] O. Baadsgaard,et al. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. , 1991, Journal of immunology.
[35] G. Mierau,et al. Electron microscopy in histiocytosis X. , 1982, Ultrastructural pathology.
[36] L. Lichtenstein. Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schüller-Christian disease as related manifestations of a single nosologic entity. , 1953, A.M.A. archives of pathology.